Arizona Administrative Code (Last Updated: November 17, 2016) |
Title 4. PROFESSIONS AND OCCUPATIONS |
Chapter 38. BOARD OF HOMEOPATHIC AND INTEGRATED MEDICINE EXAMINERS |
Article 1. GENERAL |
Section R4-38-101. Definitions
All data is extracted from pdf, click here to view the pdf.
-
In addition to the definitions at A.R.S. § 32-2901, in this Chapter:
1. “Beneficial clinical usage” means that usage results of a therapy modality or treatment are documented by:
a. Clinical reports from national or international orga- nizations;
b. Professionally recognized publications of clinical indications and contraindications;
c. National or international instructional courses pro- viding training in the use of the therapy modality, or treatment; or
d. Professional peer review presentations of physi- cians’ usage results with the therapy modality or treatment at local, county, state, national or interna- tional meetings.
2. “Classical homeopathy” means a system of medical prac- tice expounded by Samuel Hahnemann in the Organon of Medicine that treats a disease by the administration of minute doses of a remedy that would in healthy persons produce symptoms of the disease treated.
3. “Complex homeopathy” means a system of medical prac- tice that combines one or more homeopathic remedies that are not described in the Organon of Medicine.
4. “EAV” means electric acupuncture according to Reinhard Voll.
5. “Fifth Pathway program” means an academic program created by the Council on Medical Education of the American Medical Association specifically for American medical students studying abroad.
6. “Generally accepted experimental criteria in homeopa- thy” means:
a. A protocol in which a therapy modality or treatment is administered in the smallest amount necessary to stimulate a healing response with a minimum of clinical aggravation of symptoms or side effects;
b. A process of recording the clinical efficacy of a ther- apy modality or treatment reflected by measure- ments of symptom aggravation or improvement, laboratory testing, and changes in physiologic func- tioning; or
c. A process by which innovative diagnostic proce- dures and devices are analyzed and evaluated according to their ability to assist a physician in assessing the degree of electrical resistance or con- duction disturbance in the totality of a patient’s pre- senting signs, symptoms, and physiologic responses
and predict or monitor the totality of the patient’s responses to a therapy modality or treatment.
7. “Homeopathic indication” means a recognized standard of practice of homeopathic practitioners that describes a sign, symptom, and physical finding that leads to the rec- ommendation of a particular substance or therapeutic pro- cedure.
8. “Metal poisoning” means a level of toxic metals present in a patient that in the professional judgment of a licensee is inconsistent with the patient’s ability to achieve opti- mal health.
9. “Proving method of administration” means testing a homeopathic drug on healthy volunteers by recording, compiling, and organizing symptoms that are developed into a repertory.
10. “Repertory” means a compilation, usually in book form, of information categorized by the different systems of the body and providing an index of symptoms and a listing of corresponding homeopathic remedies.
11. “Rubric” means a guiding symptom leading to a homeo- pathic remedy.
Historical Note
Adopted effective June 3, 1988 (Supp. 88-2). Heading
amended effective February 7, 1995 (Supp. 95-1). Sec- tion repealed; new Section made by final rulemaking at 11 A.A.R. 2008, effective July 2, 2005 (Supp. 05-2).